How to Trade This $2 Billion Biotech Name Moving Quickly Toward Profit
Here’s our covered-call idea.
The Market Is a Mess — And the Indexes Are Hiding the Truth
The indexes are terrible timing devices, and this week proves it.
The Treasury Steps In, and I Ring the Register
I reduced three biotech winners, and not because I think they are going down.
As Market Sorts Out AI, I’m Playing 2 Small-Cap Biotechs
I’ve got two biopharma stocks on my radar ahead of earnings.
Keep an Eye Out for the Chance to Sell Biotech
XBI seems to be heading toward support and a bounce would be a good chance to do some selling.
Don’t Let the Poor Market Get You Down: I See Plenty of Good Charts
A classic Monday morning bull trap has snapped, and selling pressure is ramping up again.
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO
Leveraging wound care to tackle the much larger aesthetics market.
This Small-Cap Biotech Is Turning Heads on Wall Street
Here is how I’m playing a setup in a new name with upcoming catalysts.
While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
I’m Eyeing 2 Biopharma Stocks While Everyone Else Gawks at Big Tech
Here are a couple of oncology names that are steadily moving up.